Abstract 3061: CS231295, a novel AURKB-biased multi-kinase inhibitor, demonstrates synthetic lethality in RB1-deficient tumors and potent intracranial efficacy
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Shenzhen Chipscreen Biosciences Co.
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148811155
Cites:
Cited by:
Related to:
